SEC Filings

Form 24F-2NT Federated Hermes Total For: Feb 28 May 19, 2022 07:56AM http://archive.fast-edgar.com/20220519/AR2ZS22CS222STP2222D2ZY2RCBBZ2228J42 Filed on: May 19, 2022

Form 6-K MeaTech 3D Ltd. For: May 19 May 19, 2022 07:55AM UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a‑16 OR 15d‑16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   FOR THE MONTH OF MAY 2022   COMMISSION FILE NUMBER 001-40173   MeaTech 3D Ltd. (Translation of registrant’s name into English) ... (continue reading...)

Form 8-K Indaptus Therapeutics, For: May 19 May 19, 2022 07:52AM

 

Exhibit 99.1

 

Indaptus Therapeutics Announces FDA Clearance of Investigational New Drug

Application to Initiate Phase 1 Clinical Trial of Decoy20 in Solid Tumors

 

NEW YORK (May 19, 2022) - Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for a Phase 1 clinical trial in patients with advanced solid... (continue reading...)

Form 6-K Valens Semiconductor For: May 19 May 19, 2022 07:49AM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of May 2022

Commission File Number: 001-40842

 

VALENS SEMICONDUCTOR LTD.

(Exact name of registrant as specified in its charter)

 

8 Hanagar St. POB 7152

Hod Hasharon 4501309

Israel

(Address of principal executive office)

 

Indicate by... (continue reading...)

Form DEFA14A Schrodinger, Inc. May 19, 2022 07:46AM

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.    )  

 

Filed by the Registrant ☒                 Filed by a Party other than the Registrant ☐ 

Check the appropriate box:

 

 

 

☐

 

Preliminary Proxy Statement

☐

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐

 

... (continue reading...)